Barbora Bujdosova

Good afternoon,

I would like to ask regarding PSUR evaluation. As the submission will stay the same and during the PSUR repository step we fill contact person for pharmacovigilance, will this contact person for pharmacovigilance need to have granted some role/access in IRIS and will the person recieve the notification when the new document will appear during the evaluation phase? Even if it will be different person from contact person for a product? 

Thank you very much for the answer

Kind regards,
B.B.